Analyses of medical records for people with diabetes or obesity have found a lower risk of AUD among those treated with a GLP-1
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
Certain foods are associated with stronger natural GLP-1 release, including: High-protein foods such as eggs, fish, and legumes Fibre-rich foods including vegetables, whole grains, and pulses Fermented foods that support gut health, such as yoghurt and kefir (4,5) A diet that supports gut health generally appears to support better GLP-1 activity, which is part of why gut microbiome research has become relevant to this area
Reducing by 50-100mcg often resolves these issues while maintaining effectiveness
Brand-name Tirzepatide may be covered under some Medicare Part D or Medicare Advantage plans when prescribed for type 2 diabetes, depending on your plans formulary